Why Is 2026 The Year mRNA Moves From Pandemic Response To A Universal Cure
The technology that saved the world during the pandemic has officially graduated to its next phase in 2026. We are moving away from "Emergency Use" toward a permanent platform for "Customized Immunotherapy." This year, the focus is on mRNA-based treatments for chronic conditions like high cholesterol and heart disease, where a single injection can "program" the liver to lower dangerous protein levels for months at a time.
1 View